Axsome Therapeutics Q3 2026 Earnings Preview

Axsome Therapeutics (AXSM) is scheduled to announce Q3 earnings results on Monday, November 2nd, before market open. - The consensus EPS Estimate is -$0.64 (+31.9% Y/Y) and the consensus Revenue Estimate is $249.19M (+45.7% Y/Y). - Over the last 1 year, AXSM